Evidence suggests that nutrients involved in one-carbon metabolism are implicated in ovarian cancer etiology. No studies have evaluated the role of choline, and that of its metabolite, betaine. We prospectively examined the relationship between the intake of these nutrients and ovarian cancer risk among 159 957 participants from the Nurses' Health Study (NHS) and NHSII. The average nutrient intake was assessed every 2-4 years beginning in 1984 (for NHS) and in 1991 (for NHSII). With up to 22 years of follow-up per cohort, 526 incident cases of ovarian cancer were diagnosed. There were no associations between total choline, betaine, as well as choline plus betaine intake and ovarian cancer risk (for example, relative risk, top vs bottom quintile of choline ¼ 0.98; 95% confidence interval: 0.73-1.31; P trend ¼ 0.81). Results did not vary by alcohol consumption, folate intake or after the exclusion of cases diagnosed during the 4-year period after dietary assessment. These data provide little evidence for a role of these nutrients in ovarian cancer etiology.
Introduction
The intake of folate and nutrients involved in one-carbon metabolism has been implicated in the etiology of cancer because of their role in mediating the transfer of moieties required for DNA methylation and de novo purine and thymidylate synthesis (Kim, 1999) . For ovarian cancer, prospective studies have suggested an inverse relationship between dietary folate intake and risk (Tworoger et al., 2006) , whereas case-control studies have been null (Pelucchi et al., 2005) . To our knowledge, no studies have evaluated other methyl donors including choline, and its primary metabolite, betaine, in ovarian cancer. Among their diverse biological roles, both nutrients are a major source of methyl groups and ensure the supply of S-adenosylmethionine for many methylation reactions (Kim, 1999) . DNA methylation is an important epigenetic determinant of gene expression, maintenance of DNA integrity and stability, chromatin modifications and development of mutations-all events implicated in carcinogenesis (Kim, 1999) . As few modifiable risk factors for ovarian cancer exist, it is important to clarify the role of dietary factors. Thus, we prospectively examined whether betaine and choline intake was associated with the risk of developing epithelial ovarian cancer using data collected from two large cohort studies, namely the Nurses' Health Study (NHS) and the NHSII.
Materials and methods
The NHS cohort was established in 1976 comprising 121 700 female nurses (aged 30-55 years), and the NHSII was established in 1989 consisting of 116 430 female nurses (aged 25-42 years). All women completed an initial questionnaire, and were followed up biennially to update exposure status and disease diagnoses. Diet was assessed through a validated self-administered, semi-quantitative food frequency questionnaire (FFQ) (Willett et al., 1985) . Intake was assessed in 1984 , 1990 , 1994 , 1998 and 2002 (for NHS), as well as in 1991 , 1995 , 1999 and 2003 . Nutrient intake was calculated using the US Department of Agriculture food composition data (US Department of Agriculture, 2004 ) and other sources (Zeisel et al., 2003) .
We calculated the cumulative average intake of total choline and betaine (from food and supplements), adjusting for total energy intake using the nutrient residual method (Willett and Stampfer, 1986) . The women were classified into quintiles of cumulative average intakes.
Incident cases of epithelial ovarian cancer were reported on biennial questionnaires or identified through death certificate, and confirmed by medical record review by a pathologist. We excluded women at baseline (1984 ( NHS/ 1991 Cases and person-time were assigned to the appropriate intake category. Cox proportional hazards models with age in months and 2-year questionnaire cycle as the time scale were used to estimate relative risks (RRs) and 95% confidence intervals (CIs), adjusting for putative ovarian cancer risk factors. Trend tests were conducted by modeling quintile median intake levels and by calculating the Wald statistic. Data analyses were conducted separately for each cohort and then pooled using a random effects model to test for heterogeneity (DerSimonian and Laird, 1986) . P-values were based on two-sided tests and considered significant at o0.05. Analyses were conducted using SAS version 9.1 (SAS Institute, Cary, NC, USA).
Results
During 2 134 156 person-years for the NHS and NHSII combined, we observed 526 incident cases of ovarian cancer. Ovarian cancer risk factors were similar across quintiles of intake, except for body mass index and caffeine intake, which tended to be higher among women in the fifth quintile ( Table 1) .
The total dietary intake of betaine, choline and betaine plus choline, was not associated with the risk of ovarian cancer ( Table 2 ). The RRs and 95% CIs for the top vs bottom quintile were 0.98 (0.73-1.31), 0.98 (0.74-1.31) and 0.99 (0.75-1.32), respectively. The results were similar in the lagged analysis which excluded cases diagnosed 4 years after dietary intake assessment. The associations did not vary by alcohol consumption (o5 vs X5 g/day) or dietary folate intake (o400 vs X400 mg/day) (data not shown). Mother or sister had ovarian cancer according to participant's response on questionnaire; family history was evaluated using data from 1992 for NHS, because it was not available in previous cycles.
Discussion
In this first prospective evaluation of the relationship between choline and betaine intake and risk of ovarian cancer, no associations were observed and no effective modification was noted by alcohol consumption, a known folate antagonist, or dietary folate status. Choline can be made de novo or obtained through dietary sources (Zeisel and Blusztajn, 1994) . Adequate intake is necessary for phospholipid synthesis in cell membranes, trans-membrane signaling, as well as for lipid-cholesterol transport and metabolism (Zeisel and Blusztajn, 1994) . Betaine is an osmolyte that protects cells and proteins from environmental stress. As homocysteine can be remethylated into methionine by accepting a methyl group from folate or betaine, these pathways are highly interrelated, and the deficiency of one nutrient is compensated by the other. Most women in this cohort had adequate intake of folate (Tworoger et al., 2006) ; therefore, choline and betaine may not be as important as for a population with low folate intake. A key difference between the folate and choline pathways is that betaine-mediated methylation of homocysteine predominates in the liver or kidneys, whereas methylation by folate occurs in all cells throughout the body (Niculescu and Zeisel, 2002) . Given that little evidence links aberrant methylation patterns in the etiology of ovarian carcinogenesis, it is likely that epigenetic modification, particularly in the liver or kidneys, is not implicated in the development of this disease.
A major strength is the prospective nature of the NHS/ NHSII, with repeated assessment of dietary and risk factor information, allowing adequate control for confounding. A limitation is that mean intake among the women in this study was somewhat low (B327 mg/day), and the variation may not have been large enough to detect an association.
In conclusion, we found no evidence for an association between choline or betaine intake and risk of ovarian cancer. It is critical to continue to investigate a role of diet in the prevention of ovarian cancer, given the poor prognosis associated with this disease.
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